SRAX Inc ROCE
What is the ROCE of SRAX Inc?
The ROCE of SRAX Inc is 4,628.38%
What is the definition of ROCE?
Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used.
= EBIT / (assets - current liabilities)
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE of companies in the Communication Services sector on NASDAQ compared to SRAX Inc
What does SRAX Inc do?
digital marketing and data management platform delivering the tools to unlock the value of data across marketing channels. srax leads innovation in the digital advertising and consumer data market by identifying brands and content owners’ core consumers and discovering new and measurable opportunities to amplify their campaign performance.
Companies with roce similar to SRAX Inc
- VBI Vaccines has ROCE of 3,542.31%
- North European Oil Royalty Trust has ROCE of 3,719.06%
- Pasofino Gold has ROCE of 3,729.38%
- Synthesis Systems has ROCE of 3,846.25%
- PhaseBio Pharmaceuticals has ROCE of 4,146.52%
- Navidea Biopharmaceuticals Inc has ROCE of 4,619.50%
- SRAX Inc has ROCE of 4,628.38%
- Blue Apron Inc has ROCE of 5,016.13%
- ParkerVision has ROCE of 5,589.92%
- Asensus Surgical Inc has ROCE of 5,861.92%
- Whiting USA Trust II has ROCE of 7,251.43%
- Astra has ROCE of 7,618.05%
- Kalo Gold has ROCE of 8,333.61%